SHZ:000078

Shenzhen Neptunus Bioengineering Co., Ltd. · SHZ · Healthcare · CNY · FY for 2025

Figures on this page computed 2026-11-08 13:33 UTC

Last close

n/aCNY

Market data

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-2.1%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
-0.1%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
9.41Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
15.5%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed

Safety is the furthest below its sector's middle: 0.19 against 0.58 on the market's range.

All from 100

lens 2 of 9

Sales

196

2016-12-31 to 2025-12-31100 at the start196

Sales: 100.00 on 2016-12-31 to 196.00 on 2025-12-31, up 96%.

Profit

-135

2016-12-31 to 2025-12-31100 at the start-135

Profit: 100.00 on 2016-12-31 to -134.58 on 2025-12-31, down 235%.

Shares in issue

118

2016-12-31 to 2025-12-31100 at the start118

Shares in issue: 100.00 on 2016-12-31 to 117.97 on 2025-12-31, up 18%.

Sales is at 196, Profit is at -135, Shares in issue is at 118, against 100 in 2016.

Sales is at 196, Profit is at -135, Shares in issue is at 118, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100196
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Profit, where the first year is 100-135
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Shares in issue, where the first year is 100118
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY